Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A comparative analysis of lipid peroxidation processes and antioxidant defense system in Caucasian menopausal women with/without
insomnia
depending on the genotype of Clock 3111T/C gene polymorphism was performed. Two hundred and fourteen Caucasian menopausal women divided into control (without
insomnia
) and main group (with
insomnia
) were examined. Lipid peroxidation (conjugated dienes, thiobarbituric acid reactants) and antioxidant defense system parameters (?-tocopherol,
retinol
, reduced and oxidized glutathione, glutathione S-transferase, glutathione peroxidase, glutathione reductase, superoxide dismutase) were determined by spectrofluorophotometer and immunoenzymometric methods. Patients with
insomnia
carriers of the TT-genotype had a significantly higher thiobarbituric acid reactants level and glutathione peroxidase activity as compared to group with
insomnia
carriers of the minor 3111C-allele (
p
< .05). A comparative analysis of the parameters in the women of the main and control groups showed higher conjugated dienes, thiobarbituric acid reactants levels and lower
retinol
, reduced glutathione levels, glutathione reductase activity in women with
insomnia
carriers of the TT-genotype (
p
< .05). The carriers of the minor allele with
insomnia
had a higher conjugated dienes levels and lower glutathione peroxidase activity as compared to control (
p
< .05). Thus, lipid peroxidation and antioxidant system parameters in Caucasian menopausal women with
insomnia
depend on the Clock 3111T/C gene polymorphism.
...
PMID:Lipid peroxidation depends on the clock 3111T/C gene polymorphism in menopausal women with Insomnia. 3136 74